Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, today announced participation in a consortium selected to receive funding from ...

This new technology could one day significantly expand the market for gene-editing biotechs.

CHOP is partnering with Abu Dhabi to train scientists from the United Arab Emirates’ capital in its pioneering gene-editing treatments. This marks CHOP’s first overseas partnership specific to ...

Scribe Therapeutics is a Phase 1 clinical-stage biopharma developing in vivo CRISPR gene editing for disease prevention, ...

Cathie Wood of Ark Invest first bought shares of Beam Therapeutics (BEAM 4.14%), a biotech focused on precision genetic ...

Scientists have made many advances using traditional CRISPR technology, especially in medicine, but they are now seeking ways ...

It has also aggressively invested in gene editing, including its 2025 acquisition of cardiovascular disease gene-editing ...

Persistence Market Research, a leading management consulting firm, has released this update on the gene editing market. Gene editing technologies enable precise modification of DNA, transforming ...

New research shows it’s possible to edit the DNA of human embryos with more precision. But scientists warn it’s still not ...

Discover the top gene editing stocks to watch. Learn about this groundbreaking field and the companies leading advancements in genetic science.

A major study led by Macquarie University has examined the deep environmental, technological and societal challenges ...

Forbes contributors publish independent expert analyses and insights. A patient in a late-stage gene editing trial for a rare heart condition died from fatal liver complications after receiving an ...